Choosing Between Transcatheter Aortic Valve Replacement and Surgery in the Low-Risk Transcatheter Aortic Valve Replacement Era

Guson Kang; Alan Yeung

doi:10.1016/j.iccl.2021.05.001

Choosing Between Transcatheter Aortic Valve Replacement and Surgery in the Low-Risk Transcatheter Aortic Valve Replacement Era

Interv Cardiol Clin. 2021 Oct;10(4):413-422. doi: 10.1016/j.iccl.2021.05.001.

Authors

Guson Kang¹, Alan Yeung²

Affiliations

¹ Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA. Electronic address: guson@stanford.edu.
² Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA.

PMID: 34593105
DOI: 10.1016/j.iccl.2021.05.001

Abstract

The landmark results of the low surgical risk pivotal transcatheter aortic valve replacement (TAVR) trials fueled speculation that the role of surgical aortic valve replacement (SAVR) would be limited in the future. Instead, the field has pivoted away from reductive surgical risk stratification toward understanding the complex interplay of anatomy, timing, and surgical risk to optimize the lifetime management of aortic stenosis. In this review, we systematically explore the subtleties that influence the choice between TAVR and surgery in the low-risk TAVR era.

Keywords: Lifetime; Low risk; SAVR; TAVI; TAVR.

Published by Elsevier Inc.

Publication types

Review

MeSH terms

Aortic Valve / surgery
Aortic Valve Stenosis* / surgery
Heart Valve Prosthesis Implantation*
Humans
Transcatheter Aortic Valve Replacement*
Treatment Outcome